Glenn Goddard's Net Worth

$17.8 Million

Estimate Recalculated Jul 3, 2024 03:37PM EST

Who is Glenn Goddard?

Glenn Goddard has an estimated net worth of $17.8 Million. This is based on reported shares across multiple companies, which include AGIOS PHARMACEUTICALS INC, and Intellia Therapeutics, Inc..

SEC CIK

Glenn Goddard's CIK is 0001581992

Past Insider Trading and Trends

2014 was Glenn Goddard's most active year for acquiring shares with 30 total transactions. Glenn Goddard's most active month to acquire stocks was the month of February. 2014 was Glenn Goddard's most active year for disposing of shares, totalling 39 transactions. Glenn Goddard's most active month to dispose stocks was the month of July. 2021 saw Glenn Goddard paying a total of $1,005,745.83 for 139,232 shares, this is the most they've acquired in one year. In 2021 Glenn Goddard cashed out on 106,964 shares for a total of $8,431,771.48, their largest year based on trade value.

Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!

AGIOS PHARMACEUTICALS INC (AGIO) Snapshot price: $23.81

Senior Vice President, Finance

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
—
0
—
—
0
Feb 16
Form 4
—
0
$55.19
-$947,469.84
0
Scheduled
Sep 24
Form 4
—
0
$75.24
-$632,934.26
0
Scheduled
Jul 23
Form 4
—
0
$59.80
-$1,401,626.69
0
Scheduled
Jul 17
Form 4
—
0
$71.58
-$210,478.45
0
Scheduled
May 27
Form 4
—
0
$66.75
-$789,775.83
0
Scheduled
Mar 16
Form 4
—
0
—
—
0
Mar 2
Form 4
—
0
$71.71
-$127,928.36
0
Scheduled
Feb 13
Form 4
—
0
$64.65
-$1,402,734.43
0
Scheduled
Feb 9 - Feb 11
Form 4
—
0
$44.90
-$147,226.65
0
Scheduled
Nov 3
Form 4
—
0
$34.56
-$76,530.00
0
Scheduled
Oct 1
Form 4
—
0
$30.87
-$898,053.04
0
Scheduled
Sep 26
Form 4
—
0
—
—
0
Sep 24
Form 4
—
0
$24.28
-$440,351.89
0
Scheduled
Sep 2
Form 4
—
0
$23.82
-$158,926.75
0
Scheduled
Jul 1
Form 4
—
0
$21.83
-$82,248.37
0
Scheduled
May 1
Form 4
—
0
$23.17
-$88,024.73
0
Scheduled
Apr 4 - Apr 7
Form 4
—
0
$19.36
-$149,778.34
0
Scheduled
Apr 1
Form 4
—
0
$21.31
-$726,852.95
0
Scheduled
Mar 5 - Mar 7
Form 4
—
0
$17.77
-$122,180.71
0
Scheduled
Feb 18
Form 4
—
0
$15.46
-$179,835.00
0
Scheduled
Feb 10
Form 4
—
0
$13.38
-$180,778.50
0
Scheduled
Jan 27
Form 4
—
0
$17.59
-$342,433.00
0
Scheduled
Jan 21
Form 4
—
0
—
—
0
Aug 28
Form 3
—
0
—
—
0
No matching records found

Intellia Therapeutics, Inc. (NTLA) Snapshot price: $26.11

EVP, Chief Financial Officer

Form Type
Δ Own
Qty.
Price
Size ($)
Own
Filing Date
Type
Is Scheduled
Trade Dates
Form 4
+70.54%
28.63K
—
—
69.21K
Mar 1
Form 4
-11.68%
-5.37K
$29.46
-$158,052.90
40.59K
Jan 3
Form 4
+7.14%
3.06K
—
—
45.95K
Jan 1
Form 4
+178.42%
27.48K
—
—
42.89K
Mar 1
Form 4
-13.61%
-2.43K
$37.21
-$90,308.67
15.4K
Jan 4
Form 4
+20.73%
3.06K
—
—
17.83K
Jan 1
Form 4/A
—
0
—
—
0
Mar 1
Form 4
∞
14.77K
$112.24
-$113,699.12
14.77K
Jan 1 - Mar 1
Form 4
—
0
$97.35
-$576,410.28
0
Scheduled
Sep 7
Form 4
—
0
$89.22
-$4,213,959.29
0
Scheduled
Aug 30 - Aug 31
Form 4
—
0
$85.16
-$2,635,656.08
0
Scheduled
Aug 5
Form 4
—
0
—
—
0
Mar 3
Form 4
—
0
—
—
0
Mar 2
Form 4
—
0
—
—
0
Dec 18
Form 4/A
—
0
—
—
0
Nov 1
Form 4
—
0
—
—
0
Nov 1
Form 3
—
0
—
—
0
No matching records found